Wikidata

(Q66068914)

English

Phase 2 Trial of Seribantumab Plus Fulvestrant in Postmenopausal Women With Metastatic Breast Cancer

clinical trial

In more languages

Statements

short name
SHERBOC (English)
0 references
title
SHERBOC: A Double-blind, Placebo-controlled, Phase 2 Trial of Seribantumab Plus Fulvestrant in Postmenopausal Women With Hormone Receptor-positive, Heregulin Positive (HRG+), HER2 Negative Metastatic Breast Cancer (English)
0 references
country
Austria
0 references
Belgium
0 references
Canada
0 references
Germany
0 references
Spain
0 references
start time
15 August 2017
0 references
end time
April 2019
0 references
number of participants
80
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q66068914&oldid=1981980851"